CRP and Alzheimer disease: Several studies have also demonstrated an association between elevated levels of proinflammatory markers, including C-reactive protein, IL-6, and tumor necrosis factor-alpha (TNF-α), and cognitive decline as well as an increased risk of neurodegenerative disorders (e.g., AD and vascular dementia) (41–44).